0000899243-22-012144.txt : 20220324
0000899243-22-012144.hdr.sgml : 20220324
20220324194319
ACCESSION NUMBER: 0000899243-22-012144
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220322
FILED AS OF DATE: 20220324
DATE AS OF CHANGE: 20220324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vukovic Vojo
CENTRAL INDEX KEY: 0001466794
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 22767911
MAIL ADDRESS:
STREET 1: C/O SYNTA PHARMACEUTICALS CORP.
STREET 2: 45 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-22
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001466794
Vukovic Vojo
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON
MA
02210
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
0.44
2022-03-22
4
A
0
150000
0.00
A
2032-03-21
Common Stock
150000
150000
D
This option was granted on March 22, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 22, 2026.
/s/ Richard Wanstall, attorney-in-fact for Vojo Vukovic
2022-03-24